Cerity Partners LLC Raises Stock Position in Haleon plc (NYSE:HLN)

Cerity Partners LLC lifted its position in shares of Haleon plc (NYSE:HLN) by 312.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 152,235 shares of the company’s stock after buying an additional 115,342 shares during the period. Cerity Partners LLC’s holdings in Haleon were worth $1,253,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Van ECK Associates Corp lifted its holdings in Haleon by 18.7% in the 3rd quarter. Van ECK Associates Corp now owns 2,470,295 shares of the company’s stock valued at $20,578,000 after purchasing an additional 389,194 shares in the last quarter. QVIDTVM Management LLC lifted its stake in shares of Haleon by 36.8% during the third quarter. QVIDTVM Management LLC now owns 709,564 shares of the company’s stock valued at $5,911,000 after buying an additional 190,836 shares during the period. Mariner LLC boosted its position in Haleon by 32.8% during the third quarter. Mariner LLC now owns 345,866 shares of the company’s stock worth $2,881,000 after acquiring an additional 85,357 shares during the last quarter. Cambiar Investors LLC purchased a new stake in Haleon in the 4th quarter worth approximately $15,225,000. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of Haleon by 49.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 653,972 shares of the company’s stock worth $5,448,000 after purchasing an additional 216,478 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Up 1.1 %

HLN opened at $8.22 on Monday. The business has a 50 day moving average of $8.30 and a 200-day moving average of $8.29. The stock has a market capitalization of $37.53 billion, a price-to-earnings ratio of 29.36, a P/E/G ratio of 2.15 and a beta of 0.29. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. Haleon plc has a 1-year low of $7.70 and a 1-year high of $9.05.

Haleon Dividend Announcement

The business also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be issued a $0.1064 dividend. This represents a yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s dividend payout ratio (DPR) is presently 75.00%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HLN. HSBC initiated coverage on shares of Haleon in a research report on Wednesday, April 17th. They issued a “buy” rating for the company. Argus reaffirmed a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.